Advanced search
Publication Cover
Leukemia & Lymphoma Volume 42, 2001 - Issue 6
Submit an article Journal homepage
120
Views
14
CrossRef citations to date
0
Altmetric
Original Article

Rituximab Toxicity in Patients with Peripheral Blood Malignant B-cell Lymphocytosis

Stamatina Kanelli Faculty of Medicine, Charles University, Hradec Kralve, Czech Republic
,
Stephen M. Ansell Department of Internal Medicine, Division of Hematology, 920E Hilton Building, Mayo Clinic and Mayo Foundation, Rochester, MN, 55905, USA
,
Thomas M. Habermann Department of Internal Medicine, Division of Hematology, 920E Hilton Building, Mayo Clinic and Mayo Foundation, Rochester, MN, 55905, USA
,
David J. Inwards Department of Internal Medicine, Division of Hematology, 920E Hilton Building, Mayo Clinic and Mayo Foundation, Rochester, MN, 55905, USA
,
Nancy Tuinstra Department of Nursing, Mayo Clinic and Mayo Foundation, Rochester, MN, 55905, USA
&
Thomas E. Witzig Department of Internal Medicine, Division of Hematology, 920E Hilton Building, Mayo Clinic and Mayo Foundation, Rochester, MN, 55905, USACorrespondence[email protected]
Pages 1329-1337 | Published online: 01 Jul 2009

References

  • Maloney D. G., Grillo-Lopez A. J., White C. A., Bodkin D., Schilder R. J., Neidhart J. A., Janakiraman N., Foon K. A., Liles T. M., Dallaire B. K., Wey K., Royston I., Davis T., Levy R. IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma. Blood 1997; 90: 2188–2195
  • McLaughlin P., Grillo-Lopez A. J., Link B. K., Levy R., Czuczman M. S., Williams M. E., Heyman M. R., Bence-Bruckler I., White C. A., Cabanillas F., Jain V., Ho A. D., Lister J., Wey K., Shen D., Dallaire B. K. Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program. J. Clin. Oncol. 1998; 16: 2825–2833
  • Byrd J. C., Waselenko J. K., Maneatis T. J., Murphy T., Ward F. T., Monahan B. P., Sipe M. A., Donegan S., White C. A. Rituximab therapy in hematologic malignancy patients with circulating blood tumor cells: association with increased infusion-related side effects and rapid blood tumor clearance. J. Clin. Oncol. 1999; 17: 791–795
  • Winkler U., Jensen M., Manzke O., Schulz H., Diehl V., Engert A. Cytokine-release syndrome in patients with B-cell chronic lymphocytic leukemia and high lymphocyte counts after treatment with an anti-CD20 monoclonal antibody (rituximab, IDEC-C2B8). Blood 1999; 94: 2217–2224
  • Ansell S., Witzig T., Kurtin P., Jelinek D., Howell K., Markovic S., Habermann T., Klee G., Sloan J., Erlichmann C. Phase I study of interleukin-12 in combination with rituximab in patients with B-cell non-Hodgkin's lymphoma. Blood 2000; 96: 577a
  • Witzig T. E., Li C. Y., Tefferi A., Katzmann J. A. Measurement of the intensity of cell surface antigen expression in B-cell chronic lymphocytic leukemia. Am. J. Clin. Pathol. 1994; 101: 312–317
  • Tefferi A., Bartholmai B. J., Witzig T. E., Li C. Y., Hanson C. A., Phyliky R. L. Heterogeneity and clinical relevance of the intensity of CD20 and immunoglobulin light-chain expression in B-cell chronic lymphocytic leukemia. Am. J. Clin. Pathol. 1996; 106: 457–461
  • White C. A., Weaver R. L., Grillo-Lopez A. J. Antibody-targeted immunotherapy for treatment of malignancy. Annu. Rev. Med. 2001; 52: 125–145

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.